ITMIG consensus statement on the use of the WHO Histological classification of thymoma and thymic carcinoma: Refined definitions, histological criteria, and Reporting

Journal of Thoracic Oncology

Volumn 9, Issue 5, 2014, Pages 596-611

  Marx, Alexander ^a   Ströbel, Philipp ^a,b   Badve, Sunil S ^c   Chalabreysse, Lara ^d   Chan, John K C ^e   Chen, Gang ^f   De Leval, Laurence ^g   Detterbeck, Frank ^h   Girard, Nicolas ^d   Huang, Jim ⁱ   Kurrer, Michael O ^j   Lauriola, Libero ^k   Marino, Mirella ^l   Matsuno, Yoshihiro ^m   Molina, Thierry Jo ⁿ   Mukai, Kiyoshi ^o   Nicholson, Andrew G ^p   Nonaka, Daisuke ^q   Rieker, Ralf ^r   Rosai, Juan ^s   Ruffini, Enrico ^t   Travis, William D ⁱ   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c INDIANA UNIVERSITY HEALTH   (United States)

^d LOUIS PRADEL HOSPITAL   (France)

^e QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^f TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^g UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k CATHOLIC UNIVERSITY   (Italy)

^l REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^m HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

ⁿ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^o SAISEIKAI CENTRAL HOSPITAL   (Japan)

^p ROYAL BROMPTON HOSPITAL   (United Kingdom)

^q UNIVERSITY OF MANCHESTER   (United Kingdom)

^r UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^s Centro Diagnostico Italiano   (Italy)

^t UNIVERSITY OF TURIN   (Italy)

more..

Author keywords

Diagnostic criteria; Histological classification; Thymic carcinoma; Thymoma

Indexed keywords

EOSIN; HEMATOXYLIN; CD20 ANTIGEN; CD5 ANTIGEN; GLUCOSE TRANSPORTER 1; MUCIN 1; STEM CELL FACTOR RECEPTOR;

ARTICLE; CANCER CLASSIFICATION; DECISION MAKING; EPITHELIUM TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; THYMOMA; THYMUS CANCER; WORLD HEALTH ORGANIZATION; CARCINOMA; CHEMISTRY; CONSENSUS DEVELOPMENT; PATHOLOGY;

ANTIGENS, CD20; ANTIGENS, CD5; CARCINOMA; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MUCIN-1; PROTO-ONCOGENE PROTEINS C-KIT; REPRODUCIBILITY OF RESULTS; THYMOMA; THYMUS NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 84895786399     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000154     Document Type: Article

References (46)

1. Rosai J Sobin LH. World Health Organization Histological Classification of Tumours: Histological Typing of Tumours of the Thymus. Berlin-Heidelberg: Springer-Verlag 1999.
2. Müller-Hermelink HK Engel P Kuo TT et al. Tumours of the thymus. In WD Travis E Brambilla HK Müller-Hermelink CC Harris (Eds.) World Health Organization Classification of Tumours: Pathology and Genetics. Tumours of the Lung Pleura Thymus and Heart. Lyon: IARC Press 2004. Pp. 148-151.
3. Levine GD Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 1978;9:495-515.
4. Suster S Moran CA. Thymoma atypical thymoma and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999;111:826-833.
5. Okumura M Ohta M Miyoshi S et al. Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg 2002;50:189-194.
6. Ströbel P Bauer A Puppe B et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004;22:1501-1509.
7. Vandiedonck C Raffoux C Eymard B et al. Association of HLA-A in autoimmune myasthenia gravis with thymoma. J Neuroimmunol 2009;210:120-123.
8. Ströbel P Murumägi A Klein R et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 2007;211:563-571.
9. Suster S Moran CA. Problem areas and inconsistencies in the WHO classification of thymoma. Semin Diagn Pathol 2005;22:188-197.
10. Rieker RJ Hoegel J Morresi-Hauf A et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 2002;98:900-906.
11. Verghese ET den Bakker MA Campbell A et al. Interobserver variation in the classification of thymic tumours-A multicentre study using the WHO classification system. Histopathology 2008;53:218-223.
12. Jain RK Mehta RJ Henley JD Kesler KA Loehrer PJ Badve S. WHO types A and AB thymomas: not always benign. Mod Pathol 2010;23:1641-1649.
13. Moran CA Kalhor N Suster S. Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol 2010;134:793-798.
14. Nonaka D Rosai J. Is there a spectrum of cytologic atypia in type a thymomas analogous to that seen in type B thymomas A pilot study of 13 cases. Am J Surg Pathol 2012;36:889-894.
15. Vladislav IT Gökmen-Polar Y Kesler KA Loehrer PJ Sr Badve S. The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases. Mod Pathol 2013;26:1059-1064.
16. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006;81:2328-2334.
17. Ströbel P Hartmann E Rosenwald A et al. Corticomedullary differentiation and maturational arrest in thymomas. Histopathology 2014;64:557-566.
18. Suster S Moran CA. Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol 1999;23:955-962.
19. Tateyama H Saito Y Fujii Y et al. The spectrum of micronodular thymic epithelial tumours with lymphoid B-cell hyperplasia. Histopathology 2001;38:519-527.
20. Ströbel P Marino M Feuchtenberger M et al. Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. J Pathol 2005;207:72-82.
21. Marchevsky AM McKenna RJ Jr. Gupta R. Thymic epithelial neoplasms: a review of current concepts using an evidence-based pathology approach. Hematol Oncol Clin North Am 2008;22:543-562.
22. Cardillo G Carleo F Giunti R et al. Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa). Eur J Cardiothorac Surg 2010;37:819-823.
23. Marchevsky AM Gupta R McKenna RJ et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008;112:2780-2788.
24. Ströbel P Hohenberger P Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 2010;5(10 Suppl 4):S286-S290.
25. Marx A Rieker R Toker A Länger F Ströbel P. Thymic carcinoma: is it a separate entity From molecular to clinical evidence. Thorac Surg Clin 2011;21:25-31 v.
26. Weissferdt A Moran CA. Thymic carcinoma part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 2012;138:103-114.
27. Moran CA Suster S. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am 2008;22:393-407.
28. Kojika M Ishii G Yoshida J et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker GLUT-1 in thymic epithelial neoplasms. Mod Pathol 2009;22:1341-1350.
29. Kaira K Endo M Abe M et al. Biologic correlation of 2-[ 18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 2010;28:3746-3753.
30. Hishima T Fukayama M Fujisawa M et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-275.
31. Henley JD Cummings OW Loehrer PJ Sr. Tyrosine kinase receptor expression in thymomas. J Cancer Res Clin Oncol 2004;130:222-224.
32. Moran CA Suster S. On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas. Am J Clin Pathol 2000;114:760-766.
33. Wick MR. Histopathologic prognosis of thymomas: another example of medical surrogacy. Am J Clin Pathol 2010;134:703-705.
34. Engel P Marx A Müller-Hermelink HK. Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993. Pathol Res Pract 1999;195:565-570.
35. Chen G Marx A Chen WH et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-429.
36. Okumura M Shiono H Inoue M et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol 2007;95:40-44.
37. Chalabreysse L Roy P Cordier JF Loire R Gamondes JP Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002;26:1605-1611.
38. Suster S Moran CA. Thymoma classification: current status and future trends. Am J Clin Pathol 2006;125:542-554.
39. Nakagawa K Matsuno Y Kunitoh H Maeshima A Asamura H Tsuchiya R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005;128:140-144.
40. Jaffe E Stein H Swerdlow SH et al. B-cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In SH Swerdlow E Campo NL Harris et al. (Eds.) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press 2008. Pp. 267-268.
41. Buckley C Douek D Newsom-Davis J Vincent A Willcox N. Mature long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 2001;50:64-72.
42. Ströbel P Helmreich M Menioudakis G et al. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood 2002;100:159-166.
43. Hartert M Ströbel P Dahm M Nix W Marx A Vahl CF. A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis. Am J Surg Pathol 2010;34:742-745.
44. Kim WY Kim H Jeon YK Kim CW. Follicular dendritic cell sarcoma with immature T-cell proliferation. Hum Pathol 2010;41:129-133.
45. Moran CA Walsh G Suster S Kaiser L. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 2012;137:451-461.
46. Travis WD Brambilla E Noguchi M et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.